The inhibition by flunarizine of the norepinephrine-evoked contraction and calcium influx in rat aorta and mesenteric arteries.
D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D002118:Calcium / Q000378:metabolism*; D002936:Cinnarizine / Q000031:analogs & derivatives / Q000494:pharmacology*; D005260:Female; D005444:Flunarizine; D066298:In Vitro Techniques; D008638:Mesenteric Arteries / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000378:metabolism; D009638:Norepinephrine / Q000037:antagonists & inhibitors*; D010879:Piperazines / Q000494:pharmacology*; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects
D010879:Piperazines; D013565:Sympatholytics; D002936:Cinnarizine; D005444:Flunarizine; D011188:Potassium; D002118:Calcium; D009638:Norepinephrine